ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "neutrophils"

  • Abstract Number: 2266 • ACR Convergence 2022

    Platelet-selectin Prime Lupus Neutrophils to Produce Mitochondrial ROS and Participate in SLE Pathogenesis

    Marc Scherlinger1, Pierre Vacher2, Vivien Guillotin3, Isabelle Douchet4, Christophe Richez5 and Patrick Blanco4, 1BIDMC Harvard University, Boston, MA, 2INSERM U1218, Bordeaux, France, 3CHU de Bordeaux, Bordeaux, France, 4UMR-CNRS 5164 Immunoconcept, Bordeaux, France, 5CHRU Bordeaux, Bordeaux, France

    Background/Purpose: In patients with active systemic lupus erythematosus (SLE), circulating platelets have an activated phenotype characterized by the expression of P-selectin (CD62P). We have shown…
  • Abstract Number: 0693 • ACR Convergence 2022

    Low Neutrophil Ectonucleotidase Activity Drives Neutrophil-Platelet Aggregation and Platelet Activation in Antiphospholipid Syndrome (APS)

    Naveen Kumar S K1, Claire Hoy1, Srilakshmi Yalavarthi1, Cyrus Sarosh2, Kaitlyn Sabb1, Christine Rysenga1, Jacqueline Madison1, Yu Zuo1 and Jason S Knight3, 1University of Michigan, Ann Arbor, MI, 2University of Michigan, Temperance, MI, 3University of Michigan, Division of Rheumatology, Ann Arbor, MI

    Background/Purpose: By converting extracellular ATP into homeostatic adenosine, the ectonucleotidases CD39 (ATP to AMP) and CD73 (AMP to adenosine) dictate extracellular purinergic gradients and as…
  • Abstract Number: 2269 • ACR Convergence 2022

    Anti-NET Antibodies in Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

    Yu (Ray) Zuo1, Sherwin Navaz1, Alex Tsodikov1, Katarina Kmetova2, Claire Hoy1, Srilakshmi Yalavarthi1, Danieli Castro Oliveira de Andrade3, Maria G. Tektonidou4, Savino Sciascia5, Vittorio Pengo6, Guillermo Ruiz-Irastorza7, H Michael Belmont8, maria gerosa9, Paul fortin10, Guilherme de Jesús11, D. Ware Branch12, Laura Andreoli13, Esther Rodriguez Almaraz14, Michelle Petri15, Ricard Cervera16, Rohan Willis17, Doruk Erkan18 and Jason S Knight19, 1University of Michigan, Ann Arbor, MI, 2Division of Rheumatology, University of Michigan, Ann Arbor, MI, 3Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 4National and Kapodistrian University of Athens, Athens, Greece, 5University of Turin, Torino, Italy, 6Padova University Hospital, Padova, Italy, 7Autoimmune Diseases Research Unit, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Barakaldo, Spain, 8NYU School of Medicine, New York, NY, 9University of Milan, Milano, Italy, 10CHU de Québec, Pavillon CHUL, Québec, Canada, 11Universidade do Estado do Rio de Janeiro, Rio De Janeiro, Brazil, 12University of Utah, Salt Lake City, UT, 13Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy, 14Hospital Universitario 12 de Octubre, Madrid, Spain, 15Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, MD, 16Hospital Clínic de Barcelona, Barcelona, Spain, 17University of Texas Medical Branch, Galveston, TX, 18Hospital for Special Surgery, New York, NY, 19University of Michigan, Division of Rheumatology, Ann Arbor, MI

    Background/Purpose: The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils plays a role in the thromboinflammatory phenotype of APS. Previous work has demonstrated that…
  • Abstract Number: 0877 • ACR Convergence 2022

    Neutrophils Extracellular Traps Formation May Serve as a Biomarker for Disease Activity in Oligoarticular Juvenile Idiopathic Arthritis

    Merav Heshin-Bekenstein1, Szilvia Baron2, Grant Schulert3, Anna Shusterman4, Rachel Shukrun4, Yoav Binenbaum4 and Ronit Elhasid5, 1Dana Dwek Children's Hospital, Tel Aviv Medical Center Israel, Binyamina, Israel, 2Pediatric Hemato-Oncology Research Laboratory, Tel Aviv Medical Center, Tel Aviv, Israel, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Tel Aviv Medical Center, Tel Aviv, Israel, 5Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv, Israel

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children, causing significant morbidity. Despite the dramatic improvement in treatment, many patients…
  • Abstract Number: 2271 • ACR Convergence 2022

    Circulating Calprotectin: A Potential New Biomarker for “Non-Criteria” Clinical Manifestations of Antiphospholipid Syndrome

    Claire Hoy1, Naveen Kumar S K1, Sherwin Navaz1, Srilakshmi Yalavarthi1, Cyrus Sarosh2, Noah Peters1, Tristin Smith1, Gary Norman3, Gabriel Figueroa Parra4, Johann Gudjonsson1, J. Michelle Kahlenberg1, Jacqueline Madison1, Ali Duarte-Garcia4, Jason S Knight5 and Yu (Ray) Zuo1, 1University of Michigan, Ann Arbor, MI, 2University of Michigan, Temperance, MI, 3INOVA Diagnostics, San Diego, CA, 4Mayo Clinic, Rochester, MN, 5University of Michigan, Division of Rheumatology, Ann Arbor, MI

    Background/Purpose: While thrombosis and pregnancy loss are the best-known features of APS, many patients also exhibit "non-criteria" manifestations such as thrombocytopenia and heart valve damage.…
  • Abstract Number: 0047 • ACR Convergence 2021

    A Role for Neutrophils in Disease Onset and Severity of Spondyloarthritis

    Holly Rosenzweig1, Emily Vance2, Rouhin sen3, Liron Caplan4 and Ruth Napier1, 1Oregon Health & Science University, Portland, OR, 2VA Portland Health Care System, Portland, OR, 3Colorado University Anschutz Medical Campus, Denver, CO, 4Rocky Mountain Regional Veterans Affairs Medical Center (VAMC)/University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Spondyloarthritis (SpA) is a group of inflammatory diseases that includes axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA). AxSpA patients have irregular neutrophil responses, as…
  • Abstract Number: 0356 • ACR Convergence 2021

    The Role of Neutrophils in the Clinical Severity of Lupus Nephritis Patients with Concurrent Skin Disease

    Lais Osmani, Sicong Shan, Zoe Chafouleas, Jason Pettus and Sladjana Skopelja-Gardner, Dartmouth Hitchcock Medical Center, Lebanon, NH

    Background/Purpose: Skin disease affects >80% of lupus patients and has been linked to lupus nephritis (LN) flares. We recently found that skin inflammation caused by…
  • Abstract Number: 0384 • ACR Convergence 2021

    A Tough Cell: The Argument for a Biomarker of Clinical and Imaging Outcomes in Spondyloarthritis: The Neutrophil Lymphocyte Ratio and the Platelet Lymphocyte Ratio

    Rouhin Sen1, Emmeline Kim2, Elizabeth Cheng3, Kavya Ganuthula4, Meika Fang5, Gail Kerr6, Jessica Walsh7, Elizabeth Chang8, Siba Raychaudhuri9, Andreas Reimold10 and Liron Caplan11, 1University of Colorado School of Medicine/Rocky Mountain Regional Veterans Affairs Medical Center (VAMC), Denver, CO, 2University of Colorado School of Medicine, Aurora, CO, 3Rocky Mountain Regional VAMC, Aurora, CO, 4Rocky Mountain Regional VAMC/University of Colorado School of Medicine, Aurora, CO, 5David Geffen School of Medicine at UCLA/West Los Angeles Veterans Affairs Medical Center (VAMC), Los Angeles, CA, 6Washington D.C., Veterans Affairs Medical Center (VAMC)/Georgetown and Howard Universities, Washington, DC, 7Salt Lake City Veteran Affairs Medical Center (VAMC)/University of Utah Hospital, Salt Lake City, UT, 8Phoenix Veterans Affairs Medical Center (VAMC), Phoenix, AZ, 9Sacramento Veterans Affairs Medical Center (VAMC)/University of California-Davis Health, Davis, CA, 10University of Texas – Southwestern Medical Center/Dallas Veterans Affairs Medical Center (VAMC), Dallas, TX, 11Rocky Mountain Regional Veterans Affairs Medical Center (VAMC)/University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Biomarkers of disease activity/severity and imaging outcomes in axial spondyloarthritis (axSpA) remain a challenge. The most common relevant biomarker is the C-Reactive Protein (CRP),…
  • Abstract Number: 0520 • ACR Convergence 2021

    Leukocyte Immunoglobulin-like Receptor A3 Facilitates Neutrophil Extracellular Trap Formation in TLR7-induced Lupus Mice

    Hongjiang Liu1, Yundi Tang1, Chen Chen2 and Jianping Guo2, 1Peking University People's Hospital, Beijing, China (People's Republic), 2Peking University People’s Hospital, Beijing, China (People's Republic)

    Background/Purpose: Leukocyte immunoglobulin-like receptor A3 (LILRA3) is a secreted protein belongs to LILR family. Our research group previously reported that the functional LILRA3 is a…
  • Abstract Number: 0535 • ACR Convergence 2021

    Therapeutic Efficacy of a Biomimetic ALXR Agonist in Murine Systemic Lupus Erythematosus (SLE)

    Priyal Dave1, Tiange Dong1, Andrew Mead1, Isaac Asante1, Brandon Ebright1, Eugene Zhou1, RIta Li1, Nicos Petasis1, William Stohl2 and Stan Louie1, 1University of Southern California, Los Angeles, CA, 2University of Southern California Keck School of Medicine, Los Angeles, CA

    Background/Purpose: Neutrophils are key initiators and promoters of autoimmunity, including SLE, via the elaboration of neutrophil extracellular traps (NETs). We tested the efficacy of the…
  • Abstract Number: 0541 • ACR Convergence 2021

    N-formyl Methionine Peptide-mediated Neutrophil Activation in Systemic Sclerosis

    Runa Kuley1, Ryan Stultz2, Bhargavi Duvvuri2, Roger Hesselstrand3, J Lee Nelson4 and Christian Lood2, 1Division of Rheumatology, University of Washington, Seattle, WA, 2University of Washington, Seattle, WA, 3Lund University, Lund, Sweden, 4Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA

    Background/Purpose: Systemic sclerosis (SSc) is a complex systemic autoimmune disease, and its etiology is unknown. Exaggerated neutrophil activation and formation of neutrophil extracellular traps (NETs)…
  • Abstract Number: 0948 • ACR Convergence 2021

    Immunometabolism of Neutrophils in Antiphospholipid Syndrome (APS)

    Ajay Tambralli1, Alyssa Harbaugh2, Shanea Estes2, Srilakshmi Yalavarthi2, Claire Hoy2, Gautam Sule2 and Jason Knight2, 1University of Michigan, Ypsilanti, MI, 2University of Michigan, Ann Arbor, MI

    Background/Purpose: Neutrophil hyperactivity and neutrophil extracellular trap (NET) release (NETosis) appear to play roles in APS pathophysiology. Until recently, it was thought that neutrophils relied…
  • Abstract Number: 0994 • ACR Convergence 2021

    Role of SLE Associated Cytokines in Generation of Mature Neutrophils

    Neelakshi R. Jog, Julia Nguyen and Judith James, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by autoantibody production and periods of elevated disease activity. Recent studies indicate that along…
  • Abstract Number: 0998 • ACR Convergence 2021

    Increasing Age Impairs the Metabolic Adaptation of Human Neutrophils to Glucose Deprivation

    Moritz Pfeiffenberger1, Pierre-Louis Krau2, Yuling Chen3, Thomas Buttgereit4, Alexandra Damerau1, Timo Gaber1 and Frank Buttgereit4, 1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 2Charit Universittsmedizin Berlin, corporate member of Freie Universitt Berlin, Humboldt-Universitt zu Berlin, and Berlin Institute of Health, Department of Rheumatology and Clinical Immunology, Berlin, Germany, 3Charité University Medicine Berlin, Berlin, Germany, 4Charité – Universitätsmedizin Berlin, Berlin, Germany

    Background/Purpose: Age-related impairment of characteristic neutrophil functions is well described (Fortin, McDonald et al. 2008). However, experimental evidence for age-related alterations of neutrophil metabolic adaptation…
  • Abstract Number: 1430 • ACR Convergence 2021

    Autoantibodies Stabilize Neutrophil Extracellular Traps in COVID-19

    Yu Zuo1, Srilakshmi Yalavarthi1, Sherwin Navaz1, Claire Hoy1, Alyssa Harbaugh1, Kelsey Gockman1, Melanie Zuo1, Jacqueline Madison1, Hui Shi1, Yogendra Kanthi2 and Jason Knight1, 1University of Michigan, Ann Arbor, MI, 2NHLBI, NIH, Bethesda, MD

    Background/Purpose: The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu inherent to severe…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology